Title
List of Prohibited Drugs under RA 6425
Law
Ddb Board Regulation No. 5 S. 1972
Decision Date
Dec 4, 1972
The DDB Board Regulation No. 5 outlines a comprehensive list of prohibited drugs, including various opiates, cocaine, cannabis, and hallucinogens, to inform the public and enforce drug control measures.
A

Opiates Category

  • Covers various forms of opium: medicinal, raw (including powdered and granulated), tinctures, and extracts with more than 0.2% anhydrous morphine.
  • Includes different forms such as opium prepared for smoking, doss, charred opium, and poppy straw.
  • Specifies numerous opium alkaloids and derivatives including morphine, thebaine, codeine, heroin, hydrocodone, hydromorphone, oxycodone, and many others.
  • Contains an extensive list of synthetic opiates with similar physiological effects as narcotic drugs, listing various chemical substances and trade names.

Cocaine Category

  • Coca leaf preparations containing more than 0.1% cocaine are classified as cocaine.
  • Cocaine itself (methyl ester of benzoylecgonine) and its precursors like ecgonine, esters, and derivatives convertible to cocaine are prohibited.

Cannabis (Indian Hemp) Category

  • Prohibits marijuana plants including the dried flowering or fruiting parts from which resin has not been extracted.
  • Covers cannabis resin, including crude and purified forms such as hashish, tetrahydrocannabinol (THC), tinctures, and extracts.
  • Includes marijuana cigarettes or "reefer" products.

Hallucinogenics Category

  • Lists specific hallucinogenic substances such as DET, DMHP, DMT, LSD and LSD-25, mescaline, psilocine, psilocybin, SPT, DOM, bufotenine, ibogaine, peyote, and morning glory creeper.

Alfa and Beta Eucaine

  • Identifies these substances as prohibited drugs without further elaboration.

Trade Names and Scope

  • Clarifies that the list of trade names mentioned is not exhaustive.
  • The absence of a particular drug preparation from the trade name list does not imply it is not under regulatory control.

Adoption and Authority

  • The list was adopted on December 4, 1972.
  • Signed by Clemente S. Gatmaitan, M.D., M.P.H., Chairman, confirming the regulatory authority behind the issuance.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.